Iterum Therapeutics plc stock is up 144.94% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 December’s closed higher than November.
Iterum Therapeutics plc is developing sulopenem, a novel anti-infective compound with oral and IV formulations. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.